PO-26 - Whole blood rotational thromboelastometry (ROTEM) to detect hypercoagulability in patients with myeloproliferative neoplasms (MPN).

MLA

Giaccherini, C., et al. “PO-26 - Whole Blood Rotational Thromboelastometry (ROTEM) to Detect Hypercoagulability in Patients with Myeloproliferative Neoplasms (MPN).” Thrombosis Research, vol. 140 Suppl 1, Apr. 2016, pp. S185–86. EBSCOhost, https://doi.org/10.1016/S0049-3848(16)30159-1.

APA

Giaccherini, C., Verzeroli, C., Marchetti, M., Gamba, S., Piras, F., Russo, L., Tessarolo, S., Vignoli, A., Finazzi, G., Rambaldi, A., & Falanga, A. (2016). PO-26 - Whole blood rotational thromboelastometry (ROTEM) to detect hypercoagulability in patients with myeloproliferative neoplasms (MPN). Thrombosis Research, 140 Suppl 1, S185–S186. https://doi.org/10.1016/S0049-3848(16)30159-1

Chicago

Giaccherini, C, C Verzeroli, M Marchetti, S Gamba, F Piras, L Russo, S Tessarolo, et al. 2016. “PO-26 - Whole Blood Rotational Thromboelastometry (ROTEM) to Detect Hypercoagulability in Patients with Myeloproliferative Neoplasms (MPN).” Thrombosis Research 140 Suppl 1 (April): S185–86. doi:10.1016/S0049-3848(16)30159-1.